Delving into the Latest Updates on Wuhan Binhu Double Crane Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Eye Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

β-adrenoceptors(Beta adrenergic receptors)	1

以武汉滨湖双鹤药业有限责任公司生产，华润双鹤药业股份有限公司提供的丙泊酚中/长链脂肪乳注射液为受试制剂，按生物等效性试验的有关规定，与奥地利Fresenius Kabi Austria GmbH生产的丙泊酚中/长链脂肪乳注射液竟安®对比，进行两制剂在健康人体内的生物等效性研究和观察两制剂在健康人体内的药代动力学特征、药效学特征和安全性。

[Translation]

Propofol medium/long-chain emulsion injection produced by Wuhan Binhu Double Crane Pharmaceutical Co., Ltd. and provided by China Resources Double Crane Pharmaceutical Co., Ltd. was used as the test preparation. According to the relevant provisions of the bioequivalence test, it was compared with Propofol medium/long-chain emulsion injection Jing'an® produced by Fresenius Kabi Austria GmbH, Austria, to conduct a bioequivalence study of the two preparations in healthy humans and observe the pharmacokinetic characteristics, pharmacodynamic characteristics and safety of the two preparations in healthy humans.

Start Date07 Sep 2020

Sponsor / Collaborator

Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

CTR20200895 / CompletedNot Applicable

丙泊酚中/长链脂肪乳注射液在健康受试者空腹状态下的随机开放单次注射给药两周期交叉两序列生物等效性研究

[Translation] A randomized open-label, two-cycle, crossover, two-sequence bioequivalence study of propofol medium/long-chain emulsion injection in healthy subjects under fasting state

以武汉滨湖双鹤药业有限责任公司生产，华润双鹤药业股份有限公司提供的丙泊酚中/长链脂肪乳注射液为受试制剂，按生物等效性试验的有关规定，与奥地利Fresenius Kabi Austria GmbH生产的丙泊酚中/长链脂肪乳注射液竟安®对比，进行两制剂在健康人体内的生物等效性研究和观察两制剂在健康人体内的药代动力学特征、药效学特征和安全性。

[Translation]

Propofol medium/long-chain emulsion injection produced by Wuhan Binhu Double Crane Pharmaceutical Co., Ltd. and provided by China Resources Double Crane Pharmaceutical Co., Ltd. was used as the test preparation. According to the relevant provisions of the bioequivalence test, it was compared with Propofol medium/long-chain emulsion injection Jing'an® produced by Fresenius Kabi Austria GmbH, Austria, to conduct a bioequivalence study of the two preparations in healthy humans and observe the pharmacokinetic characteristics, pharmacodynamic characteristics and safety of the two preparations in healthy humans.

Start Date14 Jul 2020

Sponsor / Collaborator

Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

100 Clinical Results associated with Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Wuhan Binhu Double Crane Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data